BreathID Multi-center HCV Liver Breath Test Study

PHASE2TerminatedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Hepatitis C
Interventions
OTHER

MBT and BreathID

75 mg methacetin (c13 labelled) dissolved in 150 cc water ingested and breath collected before and after ingestion.

Trial Locations (5)

23284

Virginia Commonwealth Univeristy, Richmond

77030

Baylor College of Medicine, Houston

10029-6574

Mount Sinai School of Medicine, New York

23249-0001

U.S. Dept. of Veteran Affairs, Hunter Holmes McGuire Medical Center, Richmond

Unknown

Hadassah Medical Center, Jerusalem

Sponsors
All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

Virginia Commonwealth University

OTHER

collaborator

Hadassah Medical Organization

OTHER

collaborator

US Department of Veterans Affairs

FED

lead

Meridian Bioscience, Inc.

INDUSTRY

NCT00350714 - BreathID Multi-center HCV Liver Breath Test Study | Biotech Hunter | Biotech Hunter